openPR Logo
Press release

Leishmaniasis Treatment Market Volume Forecast and Value Chain Analysis 2017-2025

Leishmaniasis Treatment Market Volume Forecast and Value Chain

Leishmaniasis is a disease caused by the Leishmania parasites. The Leishmania parasite is a single cell protozoan, which is transmitted by the bite of the female phlebotomine sand fly infected by the parasite. There are over 20 Leishmania species reported, which are transmitted to humans by the bite of infected female phlebotomine sandflies. Furthermore, over 90 sand-fly species are known to transmit Leishmania parasites. Leishmaniasis consists of three different forms: visceral Leishmaniasis, cutaneous Leishmaniasis, and mucocutaneous Leishmaniasis. The visceral form of Leishmaniasis is also known as ‘Kala-azar’. Cutaneous Leishmaniasis is the most common form of Leishmaniasis.

Request Sample Copy of the Report @

Leishmaniasis primarily occurs due to poor hygienic conditions and thus, affects the poorest of people in the community who are facing problems such as poor housing, malnutrition, and weak immune systems. The disease is also linked to environmental changes such building of dams, irrigation schemes, deforestation, urbanization, etc. Each year, around 1.6 million new infections occur, and 47,000 deaths occur due to Leishmaniasis. 

In 95% of cases of visceral leishmaniasis (VL), the disease can be fatal if left untreated. The clinical symptoms of VL include weight loss, irregular bouts of fever, liver and spleen enlargement, and anemia. This form of Leishmaniasis is highly endemic in the Indian subcontinent and in East Africa. Cutaneous Leishmaniasis (CL) is the most common form of Leishmaniasis. It is characterized by ulcers and skin lesions on the body. This results in marks and scars on the patient’s body, which may last a lifetime and cause certain disabilities. Mucocutaneous Leishmaniasis can cause partial or total damage to the mucous lining of the mouth, nose, and throat. Persons infected with HIV have a greater risk of acquiring Leishmaniasis due to their compromised immune systems.

Globally, Africa, North America, and south East Asia are witnessing major problems due to lack of medication available to treat Leishmaniasis. High cost of the drugs restricts Leishmaniasis treatment in many endemic regions. High priority was not provided for leishmaniasis drug development programs by pharmaceutical companies, as the disease primarily affects the poor from developing nations and hence, are not able to get good returns on their research and development cost. However, increasing awareness about the disease and rise in incidence rate of the disease in other parts of the globe. Moreover, the unmet medical need is estimated to present an opportunity for all research and development programs to invest in the global leishmaniasis drugs market. Currently, no vaccination is available for the treatment of this disease, and the focus relies on chemotherapy and prevention and control measures of leishmaniasis.

The global market for leishmaniasis treatment can be segmented on the basis of type of drug used for its treatment, diagnostic method, and vector control methods. In terms of type of drug used, the market can be segmented into pentavalent antimonials like Sodium stibogluconate, SSG Meglumine antimoniate; antibiotics like  Amphotericin B, Liposomal amphotericin B, Miltefosine, Paromomycin and Pentamidine. Market segmentation based on diagnostic methods include rapid test for detection of the parasite or antibodies against it like- rK39 Dipstick, Direct Agglutination Test (DAT), Kala-azar Latex Agglutination Test (KAtex), and culture and polymerase chain reaction. Market segmentation by vector control methods include use of nets or mesh, use of sprays and insecticides effective against sandflies. Pharmaceutical companies and organizations are likely to adopt new methods and treatments due to continuous research and development in scientific technology to cure this disease. This, in turn, is likely to drive the demand for leishmaniasis treatment drugs during the forecast period.

Key players operating in the leishmaniasis treatment market include Enzon Pharmaceuticals (Abelcet), Paladin Therapeutics Inc., Gland Pharma/iOWH, Sequus Pharmaceuticals, Lifecare Innovation, and Sanofi Aventis .

Request TOC of the Report @

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Leishmaniasis Treatment Market Volume Forecast and Value Chain Analysis 2017-2025 here

News-ID: 709119 • Views: 302

More Releases from Transparecny Market Research

Half-Inch CIS Based Surveillance Camera Market Analysis, Opportunities And Forec …
CMOS Image Sensor (CIS) technology has been making significant progress since the last decade. Image sensor performance has improved substantially in the last few years. The CIS technology has witnessed commercial success since the introduction of mobile phones that possess onboard cameras. CMOS image sensors are likely to completely displace CCD imaging devices in the same way that CCD devices displaced video capture tubes during the mid-1980s. Get Report Details- The
Low Power Geolocation Market Growth and Business Opportunities in Coming Years | …
Geolocation is the process of identifying, locating, and communicating the exact location of a computer, networking device, etc. It allows location of devices based on geographical coordinates and measurement. A low-power geolocation system contains an improved tracking solution designed to track the location of devices that use low-power wireless technologies such as Bluetooth, WiFi, and Zigbee Low power geolocation technology aims to provide real-time location information about assets and users. Therefore, clearly
Battery Management System Market Scope, Analysis, Size, Share, Trends by 2027
As part of Industry 4.0 or the Fourth Industrial Revolution, the battery powered apps and cloud-based software and services are amongst the most popular buzzwords. Battery management systems that are cloud-based are becoming increasingly popular across a variety of industries, such as consumer electronics, telecom, and automotive. Increased adoption of electric cars, as well as growing emphasis on improving battery energy efficiency, are likely to boost demand for battery management
Adhesive Bandages Market 2018 By Emerging Trends, Industry Share, Regional Overv …
The global adhesive bandages market was valued at around US$ 2800 Mn in 2017. It is projected to expand at a CAGR in the range of 3.0% to 3.5% during the forecast period from 2018 to 2026. The adhesive bandages market is likely to expand in the next few years, owing to an increase in the incidence rate of injuries across the globe due to various factors such as sports

All 5 Releases